Professor Robert Falconer
Professor in Medicinal Chemistry
Expertise: Medicinal Chemistry in Cancer
Professor Falconer is a pharmacist who established one of three new medicinal chemistry teams at the University of Bradford’s Institute of Cancer Therapeutics (ICT), where he has served as Deputy Director since 2017.
His major interests include the cancer cell glycocalyx, and in the development of protease-activated anti-cancer prodrugs.
He is a founder of University spin-out company Incanthera plc and co-leads a £1.5m programme grant from Yorkshire Cancer Research. He is a member of several professional and learned societies, notably the Royal Pharmaceutical Society and is a registered pharmacist with the General Pharmaceutical Council. As a Fellow of the Royal Society of Chemistry, he has previously served as Honorary Treasurer for the RSC Central Yorkshire Local Section Trust (2012-18).